Tag archive for ‘glioblastoma brain cancer’
Jewish Business News Correspondent On Wednesday, September 2nd, 2015

NovoCure files for $300 Million IPO

NovoCure, a commercial-stage oncology company developing monotherapy treatments for glioblastoma brain cancer, filed on Monday with the SEC to raise up to $300 million in an initial public offering. The product More...

Wordpress site Developed by Fixing WordPress Problems